Source: BMC Genomics. Unidade: IQ
Subjects: PROTEÔMICA, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VELLOSO, Fernando Janczur et al. Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation. BMC Genomics, v. 20, n. 1, p. 1-20 art. 152, 2019Tradução . . Disponível em: https://doi.org/10.1186/s12864-019-5523-6. Acesso em: 06 jul. 2024.APA
Velloso, F. J., Campos, A. R., Sogayar, M. C., & Correa, R. G. (2019). Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation. BMC Genomics, 20( 1), 1-20 art. 152. doi:10.1186/s12864-019-5523-6NLM
Velloso FJ, Campos AR, Sogayar MC, Correa RG. Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation [Internet]. BMC Genomics. 2019 ; 20( 1): 1-20 art. 152.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1186/s12864-019-5523-6Vancouver
Velloso FJ, Campos AR, Sogayar MC, Correa RG. Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation [Internet]. BMC Genomics. 2019 ; 20( 1): 1-20 art. 152.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1186/s12864-019-5523-6